84
Participants
Start Date
September 14, 2024
Primary Completion Date
May 24, 2025
Study Completion Date
July 23, 2025
Sequence 1
Single treatment, intramuscularly injected. The total injection 100-150U.
Sequence 2
Single treatment, intramuscularly injected. The total injection 200-250U.
Sequence 3
Single treatment, intramuscularly injected. The total injection 350-400U.
Sequence 4
Single treatment, intramuscularly injected. The total injection ≤400U.
Sequence 5
Single treatment, intramuscularly injected.
Huashan Hospital Fudan University, Shanghai
Beijing Tsinghua Changgung Hospital, Beijing
The First Hospital of Lanzhou University, Lanzhou
The Fifth Affiliated Hospital of Guangzhou Medical University, Guangzhou
Zhujiang Hospital, Southern Medical University, Guangzhou
Huazhong University of Science and Technology Union Hospital, Shenzhen
The Second Hospital of Hebei Medical Hospital, Shijiazhuang
Luoyang Central Hospital, Luoyang
The Second Affiliated Hospital of Zhengzhou University, Zhengzhou
Renmin Hospital of Wuhan University, Wuhan
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan
The Second Xiangya Hospital of Central South University, Changsha
Huai 'an Second People's Hospital, Huai'an
Jiangsu Province Hospital, Nanjing
The Second Affiliated Hospital of Soochow University, Suzhou
Pingxiang People's Hospital, Pingxiang
Shengjing Hospital affiliated to China Medical University, Shenyang
Rizhao People's Hospital, Rizhao
Yantai Mountain Hospital, Yantai
Yangzhi Affiliated Rehabilitation Hospital of Tongji University, Shanghai
JHM BioPharma (Tonghua) Co. , Ltd.
NETWORK